Next Article in Journal
Hepato-Protective Effects of Delta-Tocotrienol and Alpha-Tocopherol in Patients with Non-Alcoholic Fatty Liver Disease: Regulation of Circulating MicroRNA Expression
Next Article in Special Issue
Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use
Previous Article in Journal
Structure-Based Function and Regulation of NCX Variants: Updates and Challenges
Previous Article in Special Issue
Anti-Proliferative Effects of Iridoids from Valeriana fauriei on Cancer Stem Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 1
10.3390/ijms24010083
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived Glucosylceramides and Ceramides

by
Shogo Takeda
1,
Akari Yoneda
1,
Kenchi Miyasaka
1,
Yoshiaki Manse
2,
Toshio Morikawa
2 and
Hiroshi Shimoda
1,*
1
Research and Development Division, Oryza Oil and Fat Chemical Co., Ltd., 1 Numata, Kitagata-Cho, Ichinomiya 493-8001, Japan
2
Pharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-Osaka 577-8502, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(1), 83; https://doi.org/10.3390/ijms24010083
Submission received: 26 November 2022 / Revised: 15 December 2022 / Accepted: 16 December 2022 / Published: 21 December 2022
(This article belongs to the Special Issue Chemopreventive Activities of Phytochemicals 2.0)
Browse Figures
Review Reports Versions Notes

Abstract

:
Ceramide (Cer) plays an important role in skin barrier functions in the stratum corneum (SC). The ingestion of food-derived glucosylceramides (GlcCer) attenuates transepidermal water loss (TEWL). However, the moisturizing effects of single molecules of GlcCer and Cer remain unclear. Therefore, we herein purified 13 GlcCer and 6 Cer, including elasticamide, which has the same structure as human Cer[AP], from rice and compared their epidermal moisturizing effects in a reconstructed human epidermal keratinization model. The results obtained showed that 10 µM of 5 GlcCer[d18:2] with a 4E,8Z sphingadienine and C18 to C26 fatty acids and 10 µg/mL of 3 Cer with C23 or C24 fatty acids significantly reduced TEWL. The moisturizing effects of these GlcCer were dependent on the length of fatty acids. Furthermore, 10 µg/mL of elasticamide increased the SC Cer contents by promoting the expression of GlcCer synthase. Electron microscopic observations revealed that 1 µM of GlcCer[d18:2(4E,8Z)/26:0] increased the number of keratohyalin granules and desmosomes. Immunostaining and Western blotting indicated that 1 µM of GlcCer[d18:2(4E,8Z)/26:0] up-regulated the expression of filaggrin and corneodesmosin, which contribute to epidermal hydration. This comparative study on epidermal moisturization by GlcCer and Cer isolated from rice revealed differences in their hydration mechanisms.

1. Introduction

The epidermis is the outermost layer of the skin and contributes to skin barrier functions and moisturization. It consists of the following four sublayers in order from the inner- to outermost layers: the stratum basal, stratum spinosum, stratum granulosum, and stratum corneum (SC). Approximately 95% of cells in the epidermis are keratinocytes. SC is formed by keratinization and performs barrier functions, such as inhibiting water evaporation and protecting against foreign substances and ultraviolet light [1,2,3]. The barrier functions of SC are maintained by the lamellar structure, which is formed by intercellular lipids and water molecules and fills the spaces between SC cells. Intercellular lipids are mainly composed of ceramide (Cer), which accounts for approximately 50%, and cholesterol, fatty acids, and cholesterol sulfates [4]. However, defective epidermal barrier functions cause skin dehydration due to poor water retention and the skin surface becomes more sensitive to non-specific stimuli, such as protein antigens and ultraviolet light. Defects also result in the release of various cytokines from inflammatory cells, leading to the development and worsening of dermatitis and itching. Therefore, it is important to retain the factors that contribute to barrier functions in order to maintain a healthy epidermis.
Cer is characterized as a sphingolipid that consists of a sphingoid base and fatty acid moiety. It is a component of the mammal cell membrane, a dominant lipid in the SC of human skin, and plays important roles in moisturization and barrier functions [5]. In a recent profiling study on Cer species in the human SC, 1327 species of Cer, including 20 major classes, were identified [6]. SC Cer is synthesized by several sequential enzymatic reactions involving the following enzymes. Serine palmitoyltransferase (SPT) and ceramide synthase (CerS) play roles in the de novo synthesis of Cer. SPT catalyzes the condensation of serine and palmitoyl-CoA as the first step of de novo synthesis [7], while CerS catalyzes the formation of the basic Cer structure through the N-acyltranslation of fatty acids [8]. Cer in SC is synthesized from glucosylceramides (GlcCer) and sphingomyelin, and GlcCer synthase (GCS), β-glucocerebrosidase (GBA), sphingomyelin synthase (SMS), and acid sphingomyelinase (ASM) are involved in the synthesis and metabolism of these Cer precursors. GCS plays a role in GlcCer synthesis [9] and GlcCer are hydrolyzed to Cer by GBA [10]. SMS catalyzes the synthesis of sphingomyelin [11], while ASM synthesizes Cer from sphingomyelin [12]. Previous studies reported that SC Cer content was significantly decreased in patients with atopic dermatitis (AD) [13] and xerosis [14] and decreases in Cer correlated with increased transepidermal water loss (TEWL) [15]. Therefore, the maintenance of or increases in SC Cer content is one of the approaches that effectively suppresses epidermal dehydration.
GlcCer are found in plant materials as a major sphingoid lipid and are widely distributed in various plants [16], while they are the precursor of SC Cer in human skin. Previous studies demonstrated that dietary plant-derived GlcCer enhanced skin barrier functions. The oral administration of GlcCer derived from rice [17,18], maize [18], konjac [19], and pineapples [20] has been reported to attenuate TEWL in hairless mice. Furthermore, human clinical tests demonstrated the epidermal hydration effects of dietary plant-derived GlcCer [19,21,22,23,24,25,26]. We also showed that the ingestion of rice-derived GlcCer improved facial conditions, including facial TEWL, lip moisture, and the size of visible pores [27]. These findings indicate that plant-derived GlcCer have the potential to improve skin barrier functions and epidermal hydration. However, it is important to note that these studies employed a crude GlcCer fraction as the test substance.
As described above, the effects of single molecules of GlcCer, distinguished by the type of fatty acid and sphingoid base, currently remain unclear. We recently isolated 13 species of GlcCer and 6 of Cer, including elasticamide, which has the same structure as human Cer[AP], from rice and examined the effects of these substances on melanogenesis [28] (Figure 1 and Figure 2). In the present study, we compared the epidermal moisturizing effects of isolated GlcCer and Cer in a human epidermal equivalent model. Based on the results obtained, the potential hydration mechanisms of GlcCer and Cer can be summarized and discussed.

2. Results

2.1. Effects of GlcCer (1–13) and Cer (14–19) on TEWL in the Reconstructed Human Epidermal Keratinization (RHEK) Model

We examined the effects of GlcCer (1–13) and Cer (14–19) on TEWL in the RHEK model to compare their moisturizing activities. The results obtained showed that 10 µM of GlcCer, which has a [d18:2(4E,8Z)] structure in the sphingoid base, including GlcCer[d18:2(4E,8Z)/18:0] (1), GlcCer[d18:2(4E,8Z)/20:0] (3), GlcCer[d18:2(4E,8Z)/22:0] (7), GlcCer[d18:2(4E,8Z)/24:0] (10), and GlcCer[d18:2(4E,8Z)/26:0] (13), significantly decreased TEWL after 7 days of treatment (Figure 3). The effects of these GlcCer were dependent on the length of fatty acids, with 13 exerting the strongest moisturizing effects. Regarding the Cer treatment, 10 µg/mL of Cer[t18:0/24:0] (14, elasticamide), Cer[t18:0/23:0] (16), and Cer[t18:1(8Z)/24:0] (18) significantly reduced TEWL, and the moisturizing effects of 14 were as strong as those of 13. Furthermore, 14 exhibited concentration-dependent activity at 1, 3, and 10 µg/mL (Figure 3, bottom).

2.2. Effects of GlcCer (1–13) and Cer (14–19) on SC Cer contents in the RHEK Model

To elucidate hydration mechanisms, we examined the effects of GlcCer (1–13) and Cer (14–19) on SC Cer contents. Regarding GlcCer, SC Cer contents were not affected by any of the tested molecules at 10 µM (Figure 4A). On the other hand, 14 and 18, which attenuated TEWL in the RHEK model, significantly increased SC Cer contents (Figure 4B). Therefore, we confirmed the concentration dependency of 14, which showed the strongest activity on TEWL improvement among the Cer examined. Additionally, 14 increased SC Cer contents in a concentration-dependent manner, with 10 µg/mL of 14 significantly increasing total Cer and Cer[NS,NDS] (Figure 5).

2.3. Effects of Elasticamide (14) on the Expression of Enzymes Related to SC Cer Synthesis in the RHEK Model

Elasticamide (14) significantly increased SC Cer contents in the RHEK model, as described above. Therefore, we examined the effects of 14 on the expression of enzymes involved in SC Cer synthesis. Figure 6A shows the effects of 14 on the mRNA expression of enzymes related to SC ceramide synthesis in the RHEK model: SPT2, CerS3, GCS, GBA, SMS2, and ASM. Furthermore, 14 significantly up-regulated the mRNA expression of GCS and SMS2 at 1 and 10 µg/mL, respectively. Figure 6B shows the effects of 14 on the protein expression of these enzymes; it significantly up-regulated the protein expression of GCS at 1 and 3 µg/mL, but not that of SMS2.

2.4. Effects of GlcCer[d18:2(4E,8Z)/26:0] (13) on Epidermal Hydration Factors in the RHEK Model

As described above, GlcCer did not affect SC Cer contents, while elasticamide (14) increased SC Cer via the up-regulation of GCS expression. Therefore, we conducted further experiments to elucidate the epidermal hydration mechanism of 13, which exerted the strongest moisturizing effects. The concentration-dependent effects of 13 (1, 3, and 10 µM) on TEWL were confirmed (Figure 7A). However, similar to the results shown in Figure 4, none of the concentrations of 13 increased SC Cer contents (Figure 7B). Accordingly, we performed electron microscopic observations of cross-sections of the RHEK model. The results obtained indicated that 1 µM of 13 increased the intercellular density of the SC layer. Furthermore, 13 appeared to increase the number of keratohyalin granules and desmosomes (Figure 7C).

2.5. Effects of GlcCer[d18:2(4E,8Z)/26:0] (13) on the Protein Expression of Filaggrin and Corneodesmosin

Since electron microscopic observations indicated that 13 increased keratohyalin granules and desmosomes, we examined the effects of 13 on the protein expression of filaggrin and corneodesmosin. Figure 8A shows immunostaining and Western blotting images of filaggrin expression. Based on immunostaining images, 13 (1 µM) appeared to up-regulate the expression of filaggrin in SC and Western blotting showed significant increases in the protein expression of filaggrin by 13 (1 and 3 µM). As shown in Figure 8B, immunostaining images suggested the up-regulated expression of corneodesmosin in SC by 13 (1 µM) and Western blotting revealed that 13 (1 µM) significantly increased the protein expression of corneodesmosin.

3. Discussion

In the present study, we isolated 13 GlcCer and 6 Cer from by-products of rice bran oil and compared their effects on epidermal moisturization in a RHEK model. We initially investigated the effects of GlcCer (1–13) and Cer (14–19) on TEWL. TEWL is the most widely used measurement to evaluate epidermal barrier functions [29]. Significant increases in TEWL are commonly observed in dry skin diseases, such as AD [30], xerosis, and psoriasis [31]. We previously reported the moisturizing effects of isolated steroidal saponins from tomato seeds and β-sitosterol 3-O-glucoside from rice on TEWL in RHEK models [32]. In the present study, all GlcCer[d18:2(4E,8Z)] (1, 3, 7, 10, and 13) significantly attenuated TEWL, whereas GlcCer[t18:1(8Z)] (2, 5, 9, and 12), GlcCer[d18:2(4E,8E)] (4, 8 and 11), and GlcCer[t18:1(4E)] (6) did not. These results suggest that the d18:2(4E,8Z) structure is required for the moisturizing effects of GlcCer. Furthermore, reductions in TEWL were dependent on the length of fatty acids, and the moisturizing effects of 10 and 13, which have C24 or more fatty acids, were detected in the earlier stages of the culture (Days 1 and 3). Therefore, a longer fatty acid length appeared to accelerate the epidermal hydration activity of GlcCer. Previous studies demonstrated the effects of plant-derived GlcCer on TEWL. Tsuji et al. reported that the oral administration of GlcCer from rice or maize attenuated TEWL in hairless mice [18], while Kuwata et al. showed that dietary GlcCer from pineapples reduced TEWL in hairless mice [20]. Our previous findings revealed that the oral administration of rice-derived GlcCer reduced TEWL in the skin of SDS-treated hairless mice [17]. However, these experiments used a mixture of GlcCer as the test substance and a comparison of the effects of single molecules of GlcCer has not yet been conducted. Therefore, the present study is the first report to compare and evaluate the effects of single molecules of GlcCer on epidermal hydration. Regarding Cer species, the significant attenuation of TEWL was observed with Cer[t18:0/24:0] (14, elasticamide), Cer[t18:0/23:0] (16), and Cer[t18:1(8Z)/24:0] (18). However, in contrast to the activities of GlcCer (10, 13), Cer[t18:0/25:0] (17) and Cer[t18:0/26:0] (19), which have more than C24 fatty acids, did not affect TEWL. Moreover, although none of the tested GlcCer[t18:1(8Z)] (2, 5, 9, and 12) affected TEWL, Cer (18) with the t18:1(8Z) structure significantly attenuated TEWL. On the other hand, Cer (14) and GlcCer (13) both reduced TEWL in the later stages of the culture (Days 5 and 7), while only GlcCer (13) attenuated TEWL from the earlier stage (Day 1). Collectively, these results revealed differences in the hydration mechanisms of GlcCer and Cer.
To elucidate the hydration mechanisms of GlcCer and Cer, we quantified SC Cer contents in the RHEK model treated with GlcCer (1–13) and Cer (14–19). In a profiling study on Cer species, 20 major classes of Cer were identified in the human SC [6]. SC Cer contents significantly decreased in patients with AD [13] and xerosis [14], and reductions in SC Cer contents resulted in epidermal water evaporation [15]. In the present study, 10 µg/mL of 14 and 18 significantly increased total SC Cer contents in the RHEK model. Moreover, 14 increased SC Cer contents in a concentration-dependent manner in concert with a significant increase in Cer[NS,NDS], which is the most abundant Cer species in the SC. Although the structure of 14 is the same as that of human Cer[AP], 14 did not increase SC Cer[AP] contents. This result suggests that the epidermal hydration mechanism of 14 does not involve a direct supply of Cer to the SC from the medium under the RHEK membrane. Therefore, we examined the effects of 14 on the mRNA and protein expression of SPT2, CerS3, GCS, GBA, SMS2, and ASM, which are involved in SC ceramide synthesis [7,8,9,10,11,12]. The results obtained showed that 14 significantly up-regulated the expression of GCS, which acts as a glucosyltransferase enzyme to synthesize GlcCer, the precursors of SC Cer [9]. Therefore, 14 increased SC Cer contents by up-regulating the expression of GCS, leading to reductions in TEWL. We demonstrated that tiliroside, the main component of strawberry seed extract, increased SC Cer[NS,NDS] by up-regulating GCS and GBA [33]. Although 14 did not significantly up-regulate the expression of GBA, its protein expression level was slightly increased. Consequently, the mechanisms by which tiliroside and 14 increase SC Cer contents are considered to be similar.
Regarding the hydration mechanism of rice GlcCer, 1, 3, 7, 10, and 13 did not affect SC Cer contents even though they significantly attenuated TEWL. Furthermore, between 1 and 10 µM of 13 did not increase SC Cer contents but dose-dependently reduced TEWL. Accordingly, the epidermal hydration mechanism of 13 differed from that of 14. Electron microscopic observations to investigate the hydration mechanism of 13 revealed that the intercellular density of SC layers was increased by 13, indicating better moisture retention. In addition, the number of keratohyalin granules appeared to be increased by 13. Keratohyalin granules are present in the stratum granulosum and consist of profilaggrin, which is a precursor of filaggrin. Although profilaggrin does not bind to keratin, it is dephosphorylated and proteolyzed into filaggrin monomers during the later stages of the keratinization process [34]. Filaggrin then provides natural moisturizing amino acids through its decomposition in the SC [35] and acts as a filament-aggregating protein [36]. Previous studies reported that the number of keratohyalin granules and filaggrin expression were reduced or absent in the skin of patients with ichthyosis vulgaris; therefore, the number of keratohyalin granules in the stratum granulosum reflect filaggrin production levels [37,38]. Herein, we examined the effects of 13 on filaggrin protein expression in the RHEK model. Immunostaining observations and Western blotting results revealed that the protein expression of filaggrin was significantly increased by 13. These results suggest that the increase in filaggrin, which functions as a natural moisturizing factor in the SC, may be the epidermal hydration mechanism of 13.
In addition, electron microscopic observations suggested an increase in the number of desmosomes by 13. Desmosomes are intercellular junctions that provide strong adhesion between epidermal cells [39,40] and their shape markedly changes from corneodesmosomes in the SC [41]. Corneodesmosin, which is specifically found in corneodesmosomes, plays a pivotal role in SC cell adhesion [42]. Furthermore, an analysis of corneodesmosin-knockout mouse skin revealed the detachment of the SC from the living layers of the epidermis, which resulted in prominent defects in barrier functions [43]. Therefore, increases in the expression of corneodesmosin are considered to be a reasonable mechanism for epidermal hydration. Immunostaining observations and Western blotting results revealed that the protein expression of corneodesmosin was significantly up-regulated by 13. Therefore, changes in corneodesmosin may be another hydration mechanism of 13 that reduces TEWL.

4. Conclusions

Herein, we demonstrated that among the 13 GlcCer isolated from rice, d18:2(4E,8Z)-type GlcCer reduced TEWL in a fatty acid length-dependent manner. The hydration mechanism of GlcCer appears to involve increases in SC density and the expression of filaggrin and corneodesmosin. Regarding the 6 isolated Cer, Cer with C23 or C24 fatty acids also reduced TEWL. Moreover, elasticamide (14) has been suggested to increase SC Cer contents (particularly Cer[NS,NDS]) via the up-regulated expression of GCS. The present study is the first to compare the epidermal moisturizing effects of GlcCer and Cer species as single compounds and reveal differences in the hydration mechanisms of GlcCer and Cer.

5. Materials and Methods

5.1. Preparation of GlcCer and Cer

To isolate GlcCer and Cer, they were purified according to our previously described methods [27,28]. The gummy by-products obtained during the manufacturing process of rice bran oil were subjected to flash column chromatography equipped with a silica gel column and evaporative liquid scattered detector (ELSD) to obtain crude GlcCer and Cer fractions. The crude GlcCer fraction was separated and repeatedly purified by HPLC to obtain GlcCer[d18:2(4E,8Z)/18:0] (1), GlcCer[t18:1(8Z)/20:0] (2), GlcCer[d18:2(4E,8Z)/20:0] (3), GlcCer[d18:2(4E,8E)/20:0] (4), GlcCer[t18:1(8Z)/22:0] (5), GlcCer[d18:1(4E)/20:0] (6), GlcCer[d18:2(4E,8Z)/22:0] (7), GlcCer[d18:2(4E,8E)/22:0] (8), GlcCer[t18:1(8Z)/24:0] (9), GlcCer[d18:2(4E,8Z)/24:0] (10), GlcCer[d18:2(4E,8E)/24:0] (11), GlcCer[t18:1(8Z)/26:0] (12), and GlcCer[d18:2(4E,8Z)/26:0] (13). The isolated yields from 1–13 were described in our previous study [28].
To obtain each Cer, the crude Cer fraction was purified by HPLC equipped with an ODS column (Capcell pak C18 SG-120, ϕ 20 × 250 mm, Osaka Soda, Osaka, Japan) and the RI detector, MeOH: tetrahydrofuran (9:1) as the mobile phase to obtain Cer[t18:0/24:0] (14, elasticamide, 9.9 mg), Cer[t18:0/22:0] (15, 6.2 mg), Cer[t18:0/23:0] (16, 7.4 mg), Cer[t18:0/25:0] (17, 4.6 mg), Cer[t18:1(8Z)/24:0] (18, 5.1 mg), and Cer[t18:0/26:0] (19, 5.5 mg). Chemical structures were identified by 1H- and 13C- NMR spectra with the referenced values listed in previous studies [44,45,46,47,48,49].

5.2. Reagents

Trypsin (0.25 w/v%)/EDTA (1 mmol/L)·4Na solution with phenol red (trypsin/EDTA solution), phosphate-buffered saline (PBS), L.A.B solution, 3,3′-diaminobenzidine (DAB) tablets, Mayer’s Hematoxylin Solution, and skim milk were obtained from FUJIFILM Wako Pure Chemical Co., Ltd. (Osaka, Japan). The RNeasy® Mini Kit was purchased from QIAGEN (Hilden, Germany). PrimeScriptTM Reverse Transcriptase and TB Green® Premix Dimer EraserTM were purchased from Takara Bio Inc. (Kusatsu, Japan). The dNTP mixture, random primers, and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody (GA1R) were purchased from Invitrogen (Carlsbad, CA, USA). The high performance thin-layer chromatography (HPTLC) plate, horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG and HRP-conjugated goat anti-mouse IgG were purchased from Merck Millipore (Darmstadt, Germany). The standard compounds of Cer[NS,NDS] and [AS] were purchased from Matreya LLC (State College, PA, USA). Radioimmunoprecipitation assay lysis buffer, the protease phosphatase inhibitor cocktail, BCA protein assay kit, SuperSignal™ West Pico PLUS Chemiluminescent Substrate, and SuperSignal™ West Femto Maximum Sensitivity Substrate were purchased from Thermo Fisher Scientific Inc. (Waltham, MA, USA). Anti-SPT2 (ab23696), anti-CerS3 (ab28637), anti-ASM (ab83354), anti-filaggrin (ab17808), and anti-corneodesmosin (ab204235) antibodies were obtained from Abcam, Inc. (Cambridge, UK). Anti-GCS (sc-50511) and anti-SMS2 (sc-34048) antibodies were purchased from Santa Cruz Biotechnology, Inc. (Littleton, CO, USA). An anti-GBA antibody (G4171) was supplied by Sigma-Aldrich Co., LLC (St. Louis, MO, USA).

5.3. Culture of a Reconstructed Human Epidermal Keratinization (RHEK) Model

A RHEK model (LabCyte EPI-MODEL) and assay medium obtained from Japan Tissue Engineering Co., Ltd. (Gamagori, Japan) were used in the experiments. Each cup of the RHEK models were placed into a 24-well culture plate and assay medium was added underneath the cup. After incubating the plate at 37 °C under a 5% CO2 atmosphere for 1 day, the RHEK model was treated with solutions of GlcCer (1–13) or Cer (14–19) (final DMSO concentration: 0.1%). Culture times were selected for each experiment. The RHEK model was cultured for 7 days and then subjected to TEWL measurements, a lipid analysis, Western blotting, and microscopic observations, or for 2 days followed by real-time RT-PCR.

5.4. Measurement of TEWL in the RHEK Model

TEWL measurements were performed according to previously described methods [32,50,51]. Measurements were conducted before and 1, 3, 5, and 7 days after the treatment of samples with Tewitro TW24 (Courage + Khazaka, Cologne, Germany), which is the device specifically developed for the TEWL measurement in vitro testing and can directly and simultaneously measure the TEWL of the RHEK model in a 24-well plate. The RHEK model was placed on a thermal insulation mat (HIENAI Mat; Cosmo Bio Co., Ltd., Tokyo, Japan), which consistently kept the entire bottom surface at 32 °C, without a lid for 5 min before measurements. TEWL was measured for 30 min by inserting the sensor of Tewitro TW24 into each well of the RHEK model while maintaining the bottom surface at 32 °C, and the mean value for the last 10 min was used in the analysis. Measurements were performed under sterile conditions.

5.5. Lipid Extraction and Cer Determination

Lipid extraction and Cer determination were conducted according to our previously described methods [32,33,52]. SC lipids from the RHEK model were extracted using a mixture of CHCl3, MeOH, and PBS (1:2:0.8). Dried SC lipid samples were subjected to HPTLC to measure Cer contents.

5.6. Real Time RT-PCR

The mRNA expression of Cer synthesis-related enzymes in the RHEK model was measured by quantitative real-time RT-PCR according to our previously described method [32]. Extracted RNA from the whole RHEK model was reverse-transcribed to obtain cDNA. Information on specific primers was previously described [32].

5.7. Western Blotting Analysis

The Western blotting analysis described in our previous studies [33,52] was used to assess protein expression. Proteins extracted from the RHEK model were electrophoresed on 10% SDS gels and separated proteins were transferred to polyvinylidene difluoride membranes. After blocking with 5% skim milk, membranes were treated with a primary antibody followed by a secondary antibody. Anti-SPT2 (1:1000), anti-GCS (1:200), anti-CerS3 (1:1000), anti-GBA (1:1000), anti-SMS2 (1:150), anti-ASM (1:150), anti-filaggrin (1:200), anti-corneodesmosin (1:200), and anti-GAPDH (1:1000) antibodies were used as primary antibodies. HRP-conjugated goat anti-rabbit IgG (1:5000) and HRP-conjugated goat anti-mouse IgG (1:5000) were used as secondary antibodies. SuperSignal™ West Pico PLUS Chemiluminescent Substrate and SuperSignal™ West Femto Maximum Sensitivity Substrate were used for detection solutions.

5.8. Microscopic Analysis and Immunostaining

In immunohistochemistry of the RHEK model, formalin/paraformaldehyde-fixed tissues were embedded in paraffin to obtain specimens at Aichi Pathology Laboratory LLC (Mihama, Japan). Deparaffinized specimens were treated with 0.3% H2O2 in MeOH and soaked in L.A.B solution for 15 min to activate antigens. After blocking with 5% skim milk for 1 h, specimens were treated with the primary antibody followed by the secondary antibody. Anti-filaggrin (1:200) and anti-corneodesmosin (1:200) antibodies were used as the primary antibodies. HRP-conjugated goat anti-rabbit IgG (1:5000) was used as the secondary antibody. Specimens were then treated with DAB solution followed by staining with hematoxylin solution. Microscopic images were taken by a Leica DMI6000 (Leica Microsystems GmbH, Wetzlar, Germany).
Regarding electron microscopic observations of tissues, the preparation and imaging of pathological sections were consigned to the Hanaichi UltraStructure Research Institute, Co., Ltd. (Okazaki, Japan). The samples of tissues for TEM were fixed in phosphate buffered 2% glutaraldehyde, and subsequently post-fixed in 2% osmium tetra-oxide for 2 h in an ice bath. Then, the specimens were dehydrated in a graded ethanol and embedded in the epoxy resin. Ultrathin sections were obtained by ultramicrotome technique. Ultrathin sections stained with uranyl acetate for 15 min and lead staining solution for 2 min were submitted to TEM observation at 100 kV (H-7600, HITACHI Ltd., Tokyo, Japan).

5.9. Statistical Analysis

All statistical analyses were performed using Statcel (OMS Ltd., Tokyo, Japan) as an add-in to excel. All results are expressed as means ± standard errors (S.E.). The significance of differences was examined by a one-way analysis of variance followed by Dunnett’s test, with p < 0.05 or p < 0.01 indicating a significant difference.

Author Contributions

Conceptualization, S.T. and H.S.; Data curation, S.T., A.Y., K.M., Y.M., T.M. and H.S.; Formal analysis, S.T., A.Y., K.M. and Y.M.; Funding acquisition, H.S.; Investigation, S.T., T.M. and H.S.; Resources, H.S.; Methodology, S.T., A.Y. and H.S.; Project administration, H.S.; Supervision, T.M. and H.S.; Visualization, S.T., A.Y., K.M. and H.S.; Writing—original draft, S.T. and H.S.; Writing—review and editing, T.M. and H.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the New Aichi Creative Research and Development Subsidy [grant numbers: 118-20, 2020] and Oryza Oil and Fat Chemical Co., Ltd.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript.
SCstratum corneum
Cerceramide
GlcCerglucosylceramide
SPTserine palmitoyltransferase
CerSceramide synthase
GCSglucosylceramide synthase
GBAβ-glucocerebrosidase
SMSsphingomyelin synthase
ASMacid sphingomyelinase
ADatopic dermatitis
TEWLtransepidermal water loss
RHEKreconstructed human epidermal keratinization
HPTLChigh performance thin-layer chromatography
PBSphosphate buffered saline
DAB3,3′-diaminobenzidine
GAPDHglyceraldehyde 3-phosphate dehydrogenase
HRPhorseradish peroxidase
S.E.standard error

References

  1. Fluhr, J.W.; Kao, J.; Jain, M.; Ahn, S.K.; Feingold, K.R.; Elias, P.M. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J. Investig. Dermatol. 2001, 117, 44–51. [Google Scholar] [CrossRef] [Green Version]
  2. Lim, K.M. Skin epidermis and barrier function. Int. J. Mol. Sci. 2021, 22, 3035. [Google Scholar] [CrossRef]
  3. Proksch, E.; Brandner, J.M.; Jensen, J.M. The skin: An indispensable barrier. Exp. Dermatol. 2008, 17, 1063–1072. [Google Scholar] [CrossRef]
  4. Imokawa, G. Structure and function of intercellular lipis in the stratum corneum. J. Oleo. Sci. 1995, 44, 751–766. [Google Scholar] [CrossRef] [Green Version]
  5. Huang, H.C.; Chang, T.M. Ceramide 1 and ceramide 3 act synergistically on skin hydration and the transepidermal water loss of sodium lauryl sulfate-irritated skin. Int. J. Dermatol. 2008, 47, 812–819. [Google Scholar] [CrossRef]
  6. Suzuki, M.; Ohno, Y.; Kihara, A. Whole picture of human stratum corneum ceramides, including the chain-length diversity of long-chain bases. J. Lipid. Res. 2022, 63, 100235. [Google Scholar] [CrossRef]
  7. Hanada, K. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim. Biophys. Acta 2003, 1632, 16–30. [Google Scholar] [CrossRef]
  8. Levy, M.; Futerman, A.H. Mammalian ceramide synthases. IUBMB Life 2010, 62, 347–356. [Google Scholar] [CrossRef]
  9. Hamanaka, S.; Hara, M.; Nishio, H.; Otsuka, F.; Suzuki, A.; Uchida, Y. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J. Investig. Dermatol. 2002, 119, 416–423. [Google Scholar] [CrossRef] [Green Version]
  10. Takagi, Y.; Kriehuber, E.; Imokawa, G.; Elias, P.M.; Holleran, W.M. β-Glucocerebrosidase activity in mammalian stratum corneum. J. Lipid. Res. 1999, 40, 861–869. [Google Scholar] [CrossRef]
  11. Tafesse, F.G.; Ternes, P.; Holthuis, J.C. The multigenic sphingomyelin synthase family. J. Biol. Chem. 2006, 281, 29421–29425. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Jenkins, R.W.; Canals, D.; Hannun, Y.A. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell Signal 2009, 21, 836–846. [Google Scholar] [CrossRef] [Green Version]
  13. Imokawa, G.; Abe, A.; Jin, K.; Higaki, Y.; Kawashima, M.; Hidano, A. Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J. Investig. Dermatol. 1991, 96, 523–526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Akimoto, K.; Yoshikawa, N.; Higaki, Y.; Kawashima, M.; Imokawa, G. Quantitative analysis of stratum corneum lipids in xerosis and asteatotic eczema. J. Dermatol. 1993, 20, 1–6. [Google Scholar] [CrossRef]
  15. Ishikawa, J.; Shimotoyodome, Y.; Ito, S.; Miyauchi, Y.; Fujimura, T.; Kitahara, T.; Hase, T. Variations in the ceramide profile in different seasons and regions of the body contribute to stratum corneum functions. Arch. Dermatol. Res. 2013, 305, 151–162. [Google Scholar] [CrossRef]
  16. Sugawara, T.; Aida, K.; Duan, J.; Hirata, T. Analysis of glucosylceramides from various sources by liquid chromatography-ion trap mass spectrometry. J. Oleo. Sci. 2010, 59, 387–394. [Google Scholar] [CrossRef] [Green Version]
  17. Shimoda, H.; Terazawa, S.; Hitoe, S.; Tanaka, J.; Nakamura, S.; Matsuda, H.; Yoshikawa, M. Changes in ceramides and glucosylceramides in mouse skin and human epidermal equivalents by rice-derived glucosylceramide. J. Med. Food. 2012, 15, 1064–1072. [Google Scholar] [CrossRef]
  18. Tsuji, K.; Mitsutake, S.; Ishikawa, J.; Takagi, Y.; Akiyama, M.; Shimizu, H.; Tomiyama, T.; Igarashi, Y. Dietary glucosylceramide improves skin barrier function in hairless mice. J. Dermatol. Sci. 2006, 44, 101–107. [Google Scholar] [CrossRef]
  19. Uchiyama, T.; Nakano, Y.; Ueda, O.; Mori, H.; Nakashima, M.; Noda, A.; Ishizaki, C.; Mizoguchi, M. Oral intake of glucosylceramide improves relatively higher level of transepidermal water loss in mice and healthy human subjects. J. Health Sci. 2008, 54, 559–566. [Google Scholar] [CrossRef] [Green Version]
  20. Kuwata, T.; Hashimoto, T.; Ohto, N.; Kuwahara, H.; Jae, W.L.; Bamba, T.; Mizuno, M. A metabolite of dietary glucosylceramide from pineapples improves the skin barrier function in hairless mice. J. Funct. Foods 2017, 30, 228–236. [Google Scholar] [CrossRef]
  21. Guillou, S.; Ghabri, S.; Jannot, C.; Gaillard, E.; Lamour, I.; Boisnic, S. The moisturizing effect of a wheat extract food supplement on women’s skin: A randomized, double-blind placebo-controlled trial. Int. J. Cosmet. Sci. 2011, 33, 138–143. [Google Scholar] [CrossRef] [PubMed]
  22. Hirakawa, S.; Sato, A.; Hattori, Y.; Matsumoto, T.; Yokoyama, K.; Kanai, A. Dietary rice bran extract improves TEWL of whole body. Jpn. Pharmacol. Ther. 2013, 41, 1051–1059. [Google Scholar]
  23. Koikeda, T.; Tokudome, Y.; Okayasu, M.; Kobayashi, Y.; Kuroda, K.; Yamakawa, J.; Kiyosato, N.; Masuda, K.; Saito, M. Effects of peach (Prunus persica)-derived glucosylceramide on the human skin. Immunol. Endocr. Metab. Agents Med. Chem. 2017, 17, 56–70. [Google Scholar] [CrossRef] [Green Version]
  24. Mukai, K.; Shirai, H.; Koikeda, T.; Masuda, Y.; Saito, M. Skin symptom improvement test including skin moisturizing property by intake of konjac ceramide-containing food. Jpn. Pharmacol. Ther. 2018, 46, 781–799. [Google Scholar]
  25. Murakami, M.; Nishi, Y.; Harada, K.; Masuzaki, T.; Minemoto, Y.; Yanagisawa, T.; Shimizu, T.; Tsuboi, A.; Hamada, T.; Nishimura, M. Impact of oral intake of glucosylceramide extracted from pineapple on xerostomia: A double-blind randomized cross-over trial. Nutrients 2019, 11, 2020. [Google Scholar] [CrossRef] [Green Version]
  26. Yoshino, S.; Iwasaki, T.; Nojima, J.; Ohto, N.; Kuwahara, H.; Nakata, S. Effect of glucosylceramide extracted from pineapple on healthy Japanese males and females with dullness and dry skin. Jpn. Pharmacol. Ther. 2015, 43, 1593–1599. [Google Scholar]
  27. Takara, T.; Yamamoto, K.; Suzuki, N.; Yamashita, S.; Iio, S.; Noguchi, H.; Kakinuma, T.; Baba, A.; Takeda, S.; Yamada, W.; et al. Oryza Ceramide®, a rice-derived extract consisting of glucosylceramides and β-sitosterol glucoside, improves facial skin dehydration in Japanese subjects. Funct. Foods Health Dis. 2021, 11, 385–407. [Google Scholar] [CrossRef]
  28. Miyasaka, K.; Manse, Y.; Yoneda, A.; Takeda, S.; Shimizu, N.; Yamada, W.; Morikawa, T.; Shimoda, H. Anti-melanogenic effects of glucosylceramides and elasticamide derived from rice oil by-products in melanoma cells, melanocytes and human skin. J. Food. Biochem. 2022, 46, e14353. [Google Scholar] [CrossRef]
  29. Fluhr, J.W.; Feingold, K.R.; Elias, P.M. Transepidermal water loss reflects permeability barrier status: Validation in human and rodent in vivo and ex vivo models. Exp. Dermatol. 2006, 15, 483–492. [Google Scholar] [CrossRef]
  30. Seidenari, S.; Giusti, G. Objective assessment of the skin of children affected by atopic dermatitis: A study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm. Venereol. 1995, 75, 429–433. [Google Scholar]
  31. Tezuka, T.; Fang, K.T.; Yamamura, T.; Masaki, H.; Sakon, K.; Suzuki, K. Changes of TEWL value at various skin diseases. Ski. Res. 1989, 31, 153–156. [Google Scholar]
  32. Takeda, S.; Miyasaka, K.; Shrestha, S.; Manse, Y.; Morikawa, T.; Shimoda, H. Lycoperoside H, a tomato seed saponin, improves epidermal dehydration by increasing ceramide in the stratum corneum and steroidal anti-inflammatory effect. Molecules 2021, 26, 5860. [Google Scholar] [CrossRef] [PubMed]
  33. Takeda, S.; Shimoda, H.; Takarada, T.; Imokawa, G. Strawberry seed extract and its major component, tiliroside, promote ceramide synthesis in the stratum corneum of human epidermal equivalents. PLoS ONE 2018, 13, e0205061. [Google Scholar] [CrossRef] [Green Version]
  34. Sandilands, A.; Sutherland, C.; Irvine, A.D.; McLean, W.H. Filaggrin in the frontline: Role in skin barrier function and disease. J. Cell Sci. 2009, 122, 1285–1294. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. McLean, W.H. Filaggrin failure—From ichthyosis vulgaris to atopic eczema and beyond. Br. J. Dermatol. 2016, 175, 4–7. [Google Scholar] [CrossRef]
  36. Kezic, S.; Jakasa, I. Filaggrin and skin barrier function. Curr. Probl. Dermatol. 2016, 49, 1–7. [Google Scholar]
  37. Sybert, V.P.; Dale, B.A.; Holbrook, K.A. Ichthyosis vulgaris: Identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J. Investig. Dermatol. 1985, 84, 191–194. [Google Scholar] [CrossRef] [Green Version]
  38. Fleckman, P.; Brumbaugh, S. Absence of the granular layer and keratohyalin define a morphologically distinct subset of individuals with ichthyosis vulgaris. Exp. Dermatol. 2002, 11, 327–336. [Google Scholar] [CrossRef] [PubMed]
  39. Berika, M.; Garrod, D. Desmosomal adhesion in vivo. Cell Commun. Adhes. 2014, 21, 65–75. [Google Scholar] [CrossRef]
  40. Garrod, D.; Chidgey, M. Desmosome structure, composition and function. Biochim. Biophys. Acta 2008, 1778, 572–587. [Google Scholar] [CrossRef]
  41. Lefevre-Utile, A.; Braun, C.; Haftek, M.; Aubin, F. Five functional aspects of the epidermal barrier. Int. J. Mol. Sci. 2021, 22, 11676. [Google Scholar] [CrossRef] [PubMed]
  42. Jonca, N.; Leclerc, E.A.; Caubet, C.; Simon, M.; Guerrin, M.; Serre, G. Corneodesmosomes and corneodesmosin from the stratum corneum cohesion to the pathophysiology of genodermatoses. Eur. J. Dermatol. 2011, 21, 35–42. [Google Scholar] [CrossRef] [PubMed]
  43. Leclerc, E.A.; Huchenq, A.; Mattiuzzo, N.R.; Metzger, D.; Chambon, P.; Ghyselinck, N.B.; Serre, G.; Jonca, N.; Guerrin, M. Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction. J. Cell Sci. 2009, 122, 2699–2709. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Gao, J.M.; Zhang, A.L.; Chen, H.; Liu, J.K. Molecular species of ceramides from the ascomycete truffle Tuber indicum. Chem. Phys. Lipids. 2004, 131, 205–213. [Google Scholar] [CrossRef]
  45. Yaoita, Y.; Ishizuka, T.; Kakuda, R.; Machida, K.; Kikuchi, M. Structures of new ceramides from the fruit bodies of Grifola frondosa. Chem. Pharm. Bull. 2000, 48, 1356–1358. [Google Scholar] [CrossRef] [Green Version]
  46. Muralidhar, P.; Krishna, N.; Kumar, M.M.; Rao, C.B.; Rao, D.V. New sphingolipids from marine sponge Iotrochota baculifera. Chem. Pharm. Bull. 2003, 51, 1193–1195. [Google Scholar] [CrossRef]
  47. Zhu, Y.; Soroka, D.N.; Sang, S. Structure elucidation and chemical profile of sphingolipids in wheat bran and their cytotoxic effects against human colon cancer cells. J. Agric. Food Chem. 2013, 61, 866–874. [Google Scholar] [CrossRef]
  48. Huang, Q.; Tezuka, Y.; Kikuchi, T.; Nishi, A.; Tubaki, K.; Tanaka, K. Studies on metabolites of mycoparasitic fungi. II. Metabolites of Trichoderma koningii. Chem. Pharm. Bull. 1995, 43, 223–229. [Google Scholar] [CrossRef] [Green Version]
  49. Mbosso Teinkela, J.E.; Noundou, X.S.; Nguemfo, E.L.; Meyer, F.; Djoukoue, A.; Van Antwerpen, P.; Ngouela, S.; Tsamo, E.; Mpondo Mpondo, E.A.; Vardamides, J.C.; et al. Identification of compounds with anti-proliferative activity from the wood of Ficus elastica Roxb. ex Hornem. aerial roots. Fitoterapia 2016, 112, 65–73. [Google Scholar] [CrossRef]
  50. Alexander, H.; Brown, S.; Danby, S.; Flohr, C. Research techniques made simple: Transepidermal water loss measurement as a research tool. J. Investig. Dermatol. 2018, 138, 2295–2300. [Google Scholar] [CrossRef] [Green Version]
  51. Joly-Tonetti, N.; Ondet, T.; Monshouwer, M.; Stamatas, G.N. EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function. BMC Cancer 2021, 21, 5. [Google Scholar] [CrossRef] [PubMed]
  52. Takeda, S.; Terazawa, S.; Shimoda, H.; Imokawa, G. β-Sitosterol 3-O-D-glucoside increases ceramide levels in the stratum corneum via the up-regulated expression of ceramide synthase-3 and glucosylceramide synthase in a reconstructed human epidermal keratinization model. PLoS ONE 2021, 16, e0248150. [Google Scholar] [CrossRef] [PubMed]
Ijms 24 00083 g001 550
Figure 1. Chemical structures of GlcCer (1–13) isolated from GlcCer-rich rice oil by-product.
Figure 1. Chemical structures of GlcCer (1–13) isolated from GlcCer-rich rice oil by-product.
Ijms 24 00083 g001
Ijms 24 00083 g002 550
Figure 2. Chemical structures of Cer (14–19) isolated from GlcCer-rich rice oil by-product.
Figure 2. Chemical structures of Cer (14–19) isolated from GlcCer-rich rice oil by-product.
Ijms 24 00083 g002
Ijms 24 00083 g003 550
Figure 3. Effects of GlcCer (1–13) and Cer (14–19) on TEWL in the RHEK model. The RHEK model was treated for 7 days with each sample (1–13: 10 µM, 14: 1–10 µg/mL, 15–19: 10 µg/mL). TEWL measurements were performed on days 0, 1, 3, 5, and 7 using Tewitro TW24. Data are expressed as means ± S.E. (n = 3–4). Asterisks denote a significant difference from the control group, * p < 0.05, ** p < 0.01.
Figure 3. Effects of GlcCer (1–13) and Cer (14–19) on TEWL in the RHEK model. The RHEK model was treated for 7 days with each sample (1–13: 10 µM, 14: 1–10 µg/mL, 15–19: 10 µg/mL). TEWL measurements were performed on days 0, 1, 3, 5, and 7 using Tewitro TW24. Data are expressed as means ± S.E. (n = 3–4). Asterisks denote a significant difference from the control group, * p < 0.05, ** p < 0.01.
Ijms 24 00083 g003
Ijms 24 00083 g004 550
Figure 4. Effects of GlcCer (1–13) and Cer (14–19) on SC ceramide contents in RHEK models. (A) Effects of GlcCer (1–13); (B) Effects of Cer (14–19). The RHEK model was treated for 7 days with GlcCer (1–13: 10 µM) or Cer (14–19: 10 µg/mL). The extraction of lipids from the SC of the RHEK model and a high performance thin-layer chromatography (HPTLC) analysis were performed as described in the Materials and Methods section. The effects of each GlcCer are corrected for the control value. Data are expressed as means ± S.E. (n = 3–4). Asterisks denote a significant difference from the control group, ** p < 0.01.
Figure 4. Effects of GlcCer (1–13) and Cer (14–19) on SC ceramide contents in RHEK models. (A) Effects of GlcCer (1–13); (B) Effects of Cer (14–19). The RHEK model was treated for 7 days with GlcCer (1–13: 10 µM) or Cer (14–19: 10 µg/mL). The extraction of lipids from the SC of the RHEK model and a high performance thin-layer chromatography (HPTLC) analysis were performed as described in the Materials and Methods section. The effects of each GlcCer are corrected for the control value. Data are expressed as means ± S.E. (n = 3–4). Asterisks denote a significant difference from the control group, ** p < 0.01.
Ijms 24 00083 g004
Ijms 24 00083 g005 550
Figure 5. Effects of elasticamide (14) on SC ceramide contents in the RHEK model. The RHEK model was treated for 7 days with 14 (1, 3, and 10 µg/mL). The extraction of lipids from the SC of the RHEK model and a HPTLC analysis were performed as described in the Materials and Methods section. Data are expressed as means ± S.E. (n = 3–4). Asterisks denote a significant difference from the control group, * p < 0.05.
Figure 5. Effects of elasticamide (14) on SC ceramide contents in the RHEK model. The RHEK model was treated for 7 days with 14 (1, 3, and 10 µg/mL). The extraction of lipids from the SC of the RHEK model and a HPTLC analysis were performed as described in the Materials and Methods section. Data are expressed as means ± S.E. (n = 3–4). Asterisks denote a significant difference from the control group, * p < 0.05.
Ijms 24 00083 g005
Ijms 24 00083 g006 550
Figure 6. Effects of elasticamide (14) on the mRNA (A) and protein (B) expression of enzymes related to SC Cer synthesis. The RHEK model was treated for 2 days (for real-time RT-PCR) or 7 days (for Western blotting) with 14 (1–10 µg/mL). Real-time RT-PCR and a Western blotting analysis were performed as described in the Materials and Methods section. Data are expressed as means ± S.E. (n = 4). Asterisks denote a significant difference from the control group, * p < 0.05, ** p < 0.01.
Figure 6. Effects of elasticamide (14) on the mRNA (A) and protein (B) expression of enzymes related to SC Cer synthesis. The RHEK model was treated for 2 days (for real-time RT-PCR) or 7 days (for Western blotting) with 14 (1–10 µg/mL). Real-time RT-PCR and a Western blotting analysis were performed as described in the Materials and Methods section. Data are expressed as means ± S.E. (n = 4). Asterisks denote a significant difference from the control group, * p < 0.05, ** p < 0.01.
Ijms 24 00083 g006
Ijms 24 00083 g007 550
Figure 7. Effects of GlcCer[d18:2(4E,8Z)/26:0)] (13) on epidermal hydration factors in the RHEK model. (A) Changes in TEWL (n = 6); (B) SC Cer contents after the treatment with 13 for 7 days (n = 4); (C) Electron microscopic analysis of cross-sections of the RHEK model. Dotted and solid circles indicate keratohyalin granules and desmosomes, respectively. All data are expressed as means ± S.E. Asterisks denote a significant difference from the control group, * p < 0.05, ** p < 0.01.
Figure 7. Effects of GlcCer[d18:2(4E,8Z)/26:0)] (13) on epidermal hydration factors in the RHEK model. (A) Changes in TEWL (n = 6); (B) SC Cer contents after the treatment with 13 for 7 days (n = 4); (C) Electron microscopic analysis of cross-sections of the RHEK model. Dotted and solid circles indicate keratohyalin granules and desmosomes, respectively. All data are expressed as means ± S.E. Asterisks denote a significant difference from the control group, * p < 0.05, ** p < 0.01.
Ijms 24 00083 g007
Ijms 24 00083 g008 550
Figure 8. Effects of GlcCer[d18:2(4E,8Z)/26:0)] (13) on the protein expression of filaggrin (A) and corneodesmosin (B). The RHEK model was treated for 7 days with 13. Immunostaining and Western blotting were performed as described in the Materials and Methods section. Data are expressed as means ± S.E. (n = 4–5). Asterisks denote a significant difference from the control group, * p < 0.05.
Figure 8. Effects of GlcCer[d18:2(4E,8Z)/26:0)] (13) on the protein expression of filaggrin (A) and corneodesmosin (B). The RHEK model was treated for 7 days with 13. Immunostaining and Western blotting were performed as described in the Materials and Methods section. Data are expressed as means ± S.E. (n = 4–5). Asterisks denote a significant difference from the control group, * p < 0.05.
Ijms 24 00083 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Takeda, S.; Yoneda, A.; Miyasaka, K.; Manse, Y.; Morikawa, T.; Shimoda, H. Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived Glucosylceramides and Ceramides. Int. J. Mol. Sci. 2023, 24, 83. https://doi.org/10.3390/ijms24010083

AMA Style

Takeda S, Yoneda A, Miyasaka K, Manse Y, Morikawa T, Shimoda H. Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived Glucosylceramides and Ceramides. International Journal of Molecular Sciences. 2023; 24(1):83. https://doi.org/10.3390/ijms24010083

Chicago/Turabian Style

Takeda, Shogo, Akari Yoneda, Kenchi Miyasaka, Yoshiaki Manse, Toshio Morikawa, and Hiroshi Shimoda. 2023. "Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived Glucosylceramides and Ceramides" International Journal of Molecular Sciences 24, no. 1: 83. https://doi.org/10.3390/ijms24010083

APA Style

Takeda, S., Yoneda, A., Miyasaka, K., Manse, Y., Morikawa, T., & Shimoda, H. (2023). Comparative Study on Epidermal Moisturizing Effects and Hydration Mechanisms of Rice-Derived Glucosylceramides and Ceramides. International Journal of Molecular Sciences, 24(1), 83. https://doi.org/10.3390/ijms24010083

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop